BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

873 related articles for article (PubMed ID: 33031948)

  • 1. Follow-up of adults with noncritical COVID-19 two months after symptom onset.
    Carvalho-Schneider C; Laurent E; Lemaignen A; Beaufils E; Bourbao-Tournois C; Laribi S; Flament T; Ferreira-Maldent N; Bruyère F; Stefic K; Gaudy-Graffin C; Grammatico-Guillon L; Bernard L
    Clin Microbiol Infect; 2021 Feb; 27(2):258-263. PubMed ID: 33031948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013665. PubMed ID: 33620086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection.
    Schäfer E; Scheer C; Saljé K; Fritz A; Kohlmann T; Hübner NO; Napp M; Fiedler-Lacombe L; Stahl D; Rauch B; Nauck M; Völker U; Felix S; Lucchese G; Flöel A; Engeli S; Hoffmann W; Hahnenkamp K; Tzvetkov MV
    Sci Rep; 2022 May; 12(1):7249. PubMed ID: 35508524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study.
    Sudre CH; Keshet A; Graham MS; Joshi AD; Shilo S; Rossman H; Murray B; Molteni E; Klaser K; Canas LD; Antonelli M; Nguyen LH; Drew DA; Modat M; Pujol JC; Ganesh S; Wolf J; Meir T; Chan AT; Steves CJ; Spector TD; Brownstein JS; Segal E; Ourselin S; Astley CM
    Lancet Digit Health; 2021 Sep; 3(9):e577-e586. PubMed ID: 34305035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and characteristics of persistent symptoms after non-severe COVID-19: a prospective cohort study.
    Armange L; Bénézit F; Picard L; Pronier C; Guillot S; Lentz PA; Carré F; Tattevin P; Revest M
    Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2421-2425. PubMed ID: 33893570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper airway involvement in pediatric COVID-19.
    Parisi GF; Brindisi G; Indolfi C; Diaferio L; Marchese G; Ghiglioni DG; Zicari AM; Miraglia Del Giudice M
    Pediatr Allergy Immunol; 2020 Nov; 31 Suppl 26(Suppl 26):85-88. PubMed ID: 33236430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological and clinical characteristics of survivors of SARS-COV-2 infection: A descriptive study.
    Olavegogeascoechea PA; Gallardo Martinez A; Scapellato JL; Federico A
    Medwave; 2022 Oct; 22(9):e2581. PubMed ID: 36283026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.
    Patel A; Charani E; Ariyanayagam D; Abdulaal A; Denny SJ; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Sep; 26(9):1236-1241. PubMed ID: 32502645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study.
    Sampaio Rocha-Filho PA; Albuquerque PM; Carvalho LCLS; Dandara Pereira Gama M; Magalhães JE
    J Headache Pain; 2022 Jan; 23(1):2. PubMed ID: 34979899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychiatric manifestations of COVID-19 can be clustered in three distinct symptom categories.
    Mirfazeli FS; Sarabi-Jamab A; Jahanbakhshi A; Kordi A; Javadnia P; Shariat SV; Aloosh O; Almasi-Dooghaee M; Faiz SHR
    Sci Rep; 2020 Dec; 10(1):20957. PubMed ID: 33262404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of anosmia among COVID-19 patients in Taif City, Kingdom of Saudi Arabia.
    Mubaraki AA; Alrbaiai GT; Sibyani AK; Alhulayfi RM; Alzaidi RS; Almalki HS
    Saudi Med J; 2021 Jan; 42(1):38-43. PubMed ID: 33399169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Headache associated with COVID-19: Frequency, characteristics and association with anosmia and ageusia.
    Rocha-Filho PAS; Magalhães JE
    Cephalalgia; 2020 Nov; 40(13):1443-1451. PubMed ID: 33146035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anosmia or Ageusia Following COVID-19 Vaccination: A Systematic Review.
    Arabzadeh Bahri R; Esmaeilpur Abianeh F; Peisepar M; Hadi R; Basti FA; Maleki S; Radkhah H
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):164S-170S. PubMed ID: 38411125
    [No Abstract]   [Full Text] [Related]  

  • 14. New Onset of Smell and Taste Loss Are Common Findings Also in Patients With Symptomatic COVID-19 After Complete Vaccination.
    Vaira LA; De Vito A; Lechien JR; Chiesa-Estomba CM; Mayo-Yàñez M; Calvo-Henrìquez C; Saussez S; Madeddu G; Babudieri S; Boscolo-Rizzo P; Hopkins C; De Riu G
    Laryngoscope; 2022 Feb; 132(2):419-421. PubMed ID: 34812498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term persistence of olfactory and gustatory disorders in COVID-19 patients.
    Nguyen NN; Hoang VT; Lagier JC; Raoult D; Gautret P
    Clin Microbiol Infect; 2021 Jun; 27(6):931-932. PubMed ID: 33418020
    [No Abstract]   [Full Text] [Related]  

  • 16. High Prevalence of Headaches During Covid-19 Infection: A Retrospective Cohort Study.
    Poncet-Megemont L; Paris P; Tronchere A; Salazard JP; Pereira B; Dallel R; Aumeran C; Beytout J; Jacomet C; Laurichesse H; Lesens O; Mrozek N; Vidal M; Moisset X
    Headache; 2020 Nov; 60(10):2578-2582. PubMed ID: 32757419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients.
    Lee Y; Min P; Lee S; Kim SW
    J Korean Med Sci; 2020 May; 35(18):e174. PubMed ID: 32383370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and factors associated with symptom persistence: A prospective study of 429 mild COVID-19 outpatients.
    Faycal A; Ndoadoumgue AL; Sellem B; Blanc C; Dudoit Y; Schneider L; Tubiana R; Valantin MA; Seang S; Palich R; Bleibtreu A; Monsel G; Godefroy N; Itani O; Paccoud O; Pourcher V; Caumes E; Ktorza N; Chermak A; Abdi B; Assoumou L; Katlama C;
    Infect Dis Now; 2022 Mar; 52(2):75-81. PubMed ID: 34800742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
    Dixon BE; Wools-Kaloustian KK; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
    PLoS One; 2021; 16(3):e0241875. PubMed ID: 33760821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous manifestations associated with anosmia, ageusia and enteritis in SARS-CoV-2 infection - A possible pattern? Observational study and review of the literature.
    Birlutiu V; Feiereisz AI; Oprinca G; Dobritoiu S; Rotaru M; Birlutiu RM; Iancu GM
    Int J Infect Dis; 2021 Jun; 107():72-77. PubMed ID: 33887455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.